Last minute present before the Xmas 
European Commission Grants Intercept's Ocal... - PBC Foundation
European Commission Grants Intercept's Ocaliva® (obeticholic acid) Marketing Authorization
Written by
Betonarme
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
Thank you for this news.I have been waiting for this as my disease has progressed to cirrhosis despite taking urso.I can ask my consultant now next time I see him.
Jane
That is fantastic news! Hopefully the rest of the world not too far behind
Not what you're looking for?
You may also like...
FDA Drug Safety Communication: FDA warns about serious liver injury with Ocaliva (obeticholic acid) for rare chronic liver disease
It sounds alarmist, it seems mainly to be incorrect dosage given and as a patient being considered...
Obeticholic acid
https://globenewswire.com/news-release/2017/03/02/929951/0/en/NICE-Recommends-Ocaliva-obeticholic-ac
FDA Grants Priority Review for Intercept's Obeticholic Acid for the Treatment of Primary Biliary Cirrhosis. See link below
ir.interceptpharma.com/releasedetail.cfm?ReleaseID=929359
March 2014 - Passing along a 'good news' link to a press release supporting improvements with Obeticholic Acid (OCA) in patients with PBC
I'm sharing information I ran across today in regard to clinical trials with Obeticholic Acid or...
